Savara's long-reign­ing duo both re­sign in the wake of CF bust

As Savara’s cys­tic fi­bro­sis de­vel­op­ment pro­gram comes to an end, so will the CEO Rob Neville’s 12-year reign at the com­pa­ny.

Fol­low­ing him out the door is his co-founder Taneli Jouhikainen, Savara’s pres­i­dent and chief busi­ness of­fi­cer, who’s re­sign­ing to “pur­sue oth­er op­por­tu­ni­ties.” Matthew Pauls, the for­mer chief of Strong­bridge and a mem­ber of the board, is step­ping in as chair­man and in­ter­im CEO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER